Autopsy report · NCT04301388

Management of Threatened Preterm Labor by Cervical Length-based Approach or Conventional Approach

“We unable to include the participants as we expected. Only 1 case included after 4 months of recruitment so we decided to withdrawn the study. This is because of COVID-19 pandemic, result in decreasing in the number of patient visiting our insitute.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Chiang Mai University

Sponsor type

University, hospital or other

Conditions

Preterm Delivery Within 7 Day After Admission

Interventions

Transvaginal ultrasound

Participants

0

Sites

2

Countries

Thailand

Trials that died the same way

• P-Co-Li (Pulmonary Covid-19 Study)
  “Due to recruitment we decided to withdraw the study.” (76% match in meaning)
• Bilateral Versus Unilateral Strength Training After ACLR
  “This study is withdrawn due to a lack of available recruitment within the researchers' timeframe.” (75% match in meaning)
• Ozurdex Monotherapy Trial
  “The study was withdrawn due to insufficient participant enrollment.” (75% match in meaning)
• Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
  “Study was withdrawn due to lack of patient enrollment.” (75% match in meaning)
• TDCS-Augmented Prolonged Exposure Therapy
  “Study withdrawn due to delay in recruitment due to COVID-19; the PI also moved to a new institution.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.